Drug reference
Antithymocyte globulin (rabbit)
Immunosuppressant
Also known as Thymoglobulin, ATG, Antithymocyte immunoglobulin (rabbit)
Immunosuppressant
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
Manufacturer advises use only if potential benefit outweighs risk—no information available.
FDA category + note
Mechanism
Antithymocyte globulin (rabbit) is a polyclonal antibody purified from rabbit immunized with human thymic lymphocytes. It contains antibodies against many CD antigens as well as HLA antigens. It works by binding to T lymphocytes and depleting them, thereby providing a potent immunosuppressive effect.
Indications
Prophylaxis of organ rejection in renal allograft recipientsTreatment of corticosteroid-resistant allograft rejection in renal transplantation
Dosing
- Adult
- For prophylaxis of organ rejection in renal allograft recipients: 1–2.5 mg/kg daily for 3–5 days, to be given over at least 6 hours by intravenous infusion.…
Contraindications
- Infection
Side effects
Common
ChillsDiarrhoeaDysphagiaDyspnoeaFeverHypotensionInfectionLymphopeniaMyalgiaNauseaNeoplasm malignantNeoplasmsNeutropeniaReactivation of infectionSecondary malignancySepsisSkin reactionsThrombocytopeniaVomiting
Serious
- Cytokine release syndrome
- Hepatic disorders
- Hypersensitivity
- Infusion related reaction
Pregnancy & lactation
Pregnancy
Manufacturer advises use only if potential benefit outweighs risk—no information available.
Lactation
Manufacturer advises avoid—no information available.
Related guidelines
Other Immunosuppressant drugs
Ask House about Antithymocyte globulin (rabbit)
Continue into a citation-backed clinical answer with the drug context already attached.